COXFA4L2 and glioblastoma: The results of the immunofluorescence assays were consistent with the qRT-PCR and western blot assays, indicating that NDUFA4L2 levels were generally higher in GBM cell lines than in SVGp12 and HA1800 cells (Fig. 1E).